<p>Miltefosine release from selected lipid nanocapsule formulations in PBS pH 7.4 at 37°C over a 24 h-study period. Data represent mean ± SD (n = 3). The inset is an enlargement of the release profiles for the first 8h of the release study.</p
Miltefosine (MFS) is an alkylphosphocholine used for the local treatment of cutaneous metastases of ...
The data presented here are related to the research paper entitled “Chemical stability, mass loss an...
Astaxanthin release profile from mPEG-PCL polymeric micelles in PBS at 25°C (mean ± standard deviati...
<p>Size measurement of liposome formulation (varying d/l mole ratio) during storage at 4°C and after...
<p>a, in buffer paclitaxel release from PEGylated DOTAP liposome, SWNH(-CH<sub>2</sub>-CH<sub>2</sub...
<p>Properties of drug-loaded lipid nanocapsules prepared using a post-loading strategy.</p
<p>* F test (ANOVA), % R<sub>1</sub>: % reduction in each of the study groups relative to infected c...
<p>(a) Release profiles of fenofibrate from microcapsules F2 and F3 in SGF. (b) Release profiles of ...
<p>(A) Encapsulation of PTX onto GNPs with different incubation time. (B) Drug release from PGNPs at...
<p>.(a) Plain MFS-LNCs, (b) MFS-LNC-CTAB<sup>+</sup>, (c) MFS-LNC-OA and (d) MFS-LNC-OA-CTAB<sup>+</...
<p>(A) Scanning electron microscopy picture of TUDCA-loaded microspheres. Insets: particle size dist...
<p>(a) Release profiles of piroxicam from microcapsules P1 and P2 in SGF. (b) Release profile of pir...
Data for: Monoacyl-Phospatidylcholine Nanostructured Lipid Carriers: Influence of Lipid and Surfacta...
<p>Phospholipid (DPPC/DSPC = 100-X/X):DSPE-PEG:cholesterol:SA-V6 = 55∶2∶10∶0.55 (X = 0, 25, 50, 75, ...
<p>(A) DPPC:DSPE-PEG:cholesterol:SA-V3 = 55∶2∶15:Y<sub>1</sub> (Y<sub>1</sub> = 0.28, 0.41, or 0.55)...
Miltefosine (MFS) is an alkylphosphocholine used for the local treatment of cutaneous metastases of ...
The data presented here are related to the research paper entitled “Chemical stability, mass loss an...
Astaxanthin release profile from mPEG-PCL polymeric micelles in PBS at 25°C (mean ± standard deviati...
<p>Size measurement of liposome formulation (varying d/l mole ratio) during storage at 4°C and after...
<p>a, in buffer paclitaxel release from PEGylated DOTAP liposome, SWNH(-CH<sub>2</sub>-CH<sub>2</sub...
<p>Properties of drug-loaded lipid nanocapsules prepared using a post-loading strategy.</p
<p>* F test (ANOVA), % R<sub>1</sub>: % reduction in each of the study groups relative to infected c...
<p>(a) Release profiles of fenofibrate from microcapsules F2 and F3 in SGF. (b) Release profiles of ...
<p>(A) Encapsulation of PTX onto GNPs with different incubation time. (B) Drug release from PGNPs at...
<p>.(a) Plain MFS-LNCs, (b) MFS-LNC-CTAB<sup>+</sup>, (c) MFS-LNC-OA and (d) MFS-LNC-OA-CTAB<sup>+</...
<p>(A) Scanning electron microscopy picture of TUDCA-loaded microspheres. Insets: particle size dist...
<p>(a) Release profiles of piroxicam from microcapsules P1 and P2 in SGF. (b) Release profile of pir...
Data for: Monoacyl-Phospatidylcholine Nanostructured Lipid Carriers: Influence of Lipid and Surfacta...
<p>Phospholipid (DPPC/DSPC = 100-X/X):DSPE-PEG:cholesterol:SA-V6 = 55∶2∶10∶0.55 (X = 0, 25, 50, 75, ...
<p>(A) DPPC:DSPE-PEG:cholesterol:SA-V3 = 55∶2∶15:Y<sub>1</sub> (Y<sub>1</sub> = 0.28, 0.41, or 0.55)...
Miltefosine (MFS) is an alkylphosphocholine used for the local treatment of cutaneous metastases of ...
The data presented here are related to the research paper entitled “Chemical stability, mass loss an...
Astaxanthin release profile from mPEG-PCL polymeric micelles in PBS at 25°C (mean ± standard deviati...